CCL2 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma, HDAC5 could repress the suppressor of cytokine signaling 3 (SOCS3), a negative regulator of chemokine CCL2, contributing to elevated CCL2 and following recruitment of M2 macrophages [177].